SHORT ANSWER
Anything a reasonable reader takes away from the page, not only what the copy states outright. The FTC reads the “net impression” of the whole ad, including the product name, images, charts, and surrounding context. A product named for fat loss, a review describing recovery, or a “research shows” line implies an effect, and the seller is responsible for it.
This material is general educational information as of the “last reviewed” date. It is not legal advice and may not reflect later developments or facts specific to your business. Links are provided so readers can inspect the primary or official sources.
01 / EXPRESS VS IMPLIED
The seller answers for both kinds of claim
The FTC's Health Products Compliance Guidance separates what an ad says outright from what it suggests. An express claim is stated in words. An implied claim is what the reader reasonably takes from the ad even though no sentence says it.
The guidance is direct on responsibility: a marketer is “equally responsible for the accuracy of claims suggested or reasonably implied.” There is no lighter standard for the implied version.
On a peptide storefront this is the usual gap. Very few sites write “treats diabetes.” Many write a product description that walks through glucose response, appetite, and insulin sensitivity, then let the reader draw the conclusion.
02 / NET IMPRESSION
The whole page is the claim, not a phrase
The FTC evaluates the “net impression” conveyed by all elements of the ad, and the guidance names them: the text, the product name, and any charts, graphs, and other images. Marketers are told not to focus narrowly on individual phrases but to consider each ad as a whole.
That standard is why a research-use-only line does not settle the question. It is one element. The name, the imagery, the description, and the adjacent products are the others, and the reader forms one impression from all of them together.
FDA asks what the product is intended for and uses the whole presentation as evidence of that intent under 21 CFR 201.128. FTC asks what the ad leads a reasonable consumer to believe. The two lenses differ in law and land on the same material.
03 / DISCLOSURES
A disclosure qualifies a claim; it cannot reverse one
The guidance sets two tests for a disclosure. It must be clear and conspicuous, meaning easily noticeable and easily understandable by ordinary consumers. And it must fit the claim it qualifies: a disclosure “should not be contradicted or mitigated by, or inconsistent with, anything else in the ad.”
The second test is the one that matters most for this vertical. A footer stating the product is not for human use does not qualify a description of effects in people; it contradicts it. The guidance treats a disclosure that directly contradicts a claim as failing to cure it.
- Placement counts: a disclosure below the fold or behind a link is not conspicuous relative to a claim in the product title.
- Wording counts: legal phrasing an ordinary buyer would not parse does not qualify a plain-language claim.
- Consistency counts: a disclosure that the surrounding copy argues against is read as inconsistent, not as a limit.
04 / SUBSTANTIATION
“Research shows” is a claim that needs its own proof
Health claims require competent and reliable scientific evidence. The guidance defines that as tests, analyses, research, or studies conducted and evaluated objectively by experts in the relevant field, using methods generally accepted to yield accurate and reliable results.
A product page that cites clinical trials or says a compound “has been shown to” do something is making an efficacy claim and an evidence claim at once. Both need support. The guidance also expects marketers to disclose significant limitations or inconsistencies in the literature rather than presenting emerging science as settled.
Language aimed at “research subjects” or “test subjects” does not change this. If the sentence describes an effect on a body, it conveys an efficacy claim to the reader regardless of who the sentence says the body belongs to.
05 / TESTIMONIALS AND ENDORSEMENTS
A customer's words become the seller's claim
Under the guidance and the FTC's Endorsement Guides, a testimonial carries an implied claim that the product is effective, and the advertiser must have scientific evidence for that underlying claim. Testimonials that report results more dramatic than users can generally expect are likely to be deceptive, and a “results not typical” line alone does not cure that.
Material connections must be disclosed. Any personal, financial, or similar connection a consumer would not expect, such as free product, affiliate payment, or employment, has to be stated clearly. The advertiser is liable for what an endorser says, including a blogger or influencer the seller paid or supplied.
In RUO Clear's corpus of 185 FDA warning letters to peptide, GLP-1, and research-chemical sellers, testimonials were cited as efficacy evidence in 7 letters and social media content attributed to the seller in 25. That is FDA's lens, but it shows the same surfaces drawing regulator attention.
06 / ONE STANDARD
No separate lane for “structure/function” wording
The guidance states that FTC law makes no bright-line distinctions between categories of health-related products or claims. A structure/function phrasing that avoids naming a disease is evaluated under the same deception and substantiation standards as a disease claim.
For a peptide seller that means rewording “treats obesity” to “supports metabolic function” changes nothing about the evidence required. It changes only how easily the claim is spotted.
07 / APPLY IT
Read each storefront surface for its net impression
Work through the surfaces a consumer actually sees and ask what a reasonable reader takes from each one, on its own and together.
- Product names and slugs: a name built on an outcome (lean, burn, heal, recover) is an implied efficacy claim before the description loads.
- Descriptions with “research subject” framing: if the sentence describes appetite, glucose, muscle, sleep, or skin effects, it implies those effects for the buyer.
- Before-and-after imagery, body-composition photos, and charts: the guidance names images as part of the net impression.
- Reviews and star ratings: each is a testimonial; the site is responsible for the claims inside them and for typical-results disclosure.
- Blog posts and guides: educational framing does not remove a claim when the post links to the product it describes.
- Influencer and affiliate posts: the material connection must be disclosed, and the seller answers for the content.
- Bundled supplies: syringes and bacteriostatic water listed beside a peptide shape the impression of intended use as much as words do.
QUESTIONS
Related questions
If I never state a health benefit, can I still be making a health claim?
Yes. The FTC holds a marketer equally responsible for claims suggested or reasonably implied. The product name, images, and surrounding copy can imply an effect no sentence states.
Does a “results not typical” line make a testimonial safe?
No. The guidance says testimonials reporting more dramatic results than users can generally expect are likely deceptive, and that disclaimer alone does not cure it. The advertiser also needs evidence for the underlying efficacy claim.
Is “for research purposes only” a disclosure the FTC would credit?
Only to the extent it does not contradict the rest of the ad. A disclosure that is inconsistent with the surrounding claims is treated as failing to qualify them.
Can RUO Clear tell me whether my copy is deceptive?
No. A scan reports the language it observed and which guidance it maps to. Whether a specific ad is deceptive is a legal determination, not something a website review can make.
SOURCES
Sources cited
Each source is listed with its class so government authority, agency guidance, enforcement examples, and private policy are never blended into one rule.
Express and implied claims, net impression, clear and conspicuous disclosures, competent and reliable scientific evidence, and testimonials.
Typical results, material connections, and advertiser liability for endorser statements.
FDA's intended-use standard, cited here to contrast the two agencies' lenses on the same storefront material.